Novartis’ Sandoz reportedly the target of $25B buyout bid from Carlyle and Blackstone fkansteiner Tue, 02/01/2022 – 11:09
Novartis, Amgen settle their dueling lawsuits over migraine drug Aimovig esagonowsky Tue, 02/01/2022 – 10:36
Biogen’s Aduhelm support campaign backfires as CMS receives many more comments in favor of restrictive coverage: analyst fkansteiner […]
AstraZeneca runs first kidney disease focused Farxiga TV ad, getting in the homes of 37M people with this […]
CMS’ Biogen decision could spell problems for Lilly, Roche Alzheimer’s drugs, half of surveyed neurologists say badams Tue, […]
A Phase 1 clinical trial has demonstrated the safety and efficacy of a novel immunotherapy drug in the […]
Patients who leave hospital after a stay for covid-19 are far more likely to need to be readmitted […]
“People in England who are clinically extremely vulnerable and at highest risk of becoming severely ill from covid-19 […]
England’s health secretary is reportedly considering a radical shake-up of the NHS that would incentivise GPs to be […]
The government has done a last minute U turn on its plan to make covid-19 vaccination mandatory for […]